CNS pipeline · person
N. Anthony Coles, MD
Chairperson of the board of directors of Cerevel Therapeutics since December 2018; served as the company's Chief Executive Officer from September 2019 until the June 2023 appointment of Ron Renaud. Previously co-founder, chairperson and CEO of Yumanity Therapeutics, and president, CEO and chairperson of Onyx Pharmaceuticals (sold to Amgen in 2013).
- 1 company
Courtesy Cerevel Therapeutics
Current roles
- Cerevel TherapeuticsChairperson of the Board of Directors · Board2018–present
Past roles
- Cerevel TherapeuticsChief Executive Officer · Executive2019–2023
Appears with
People sharing a company with N..
- Adam Koppel · Cerevel Therapeutics
- Christopher Gordon · Cerevel Therapeutics
- Deborah Baron · Cerevel Therapeutics
- Deval Patrick · Cerevel Therapeutics
- Doug Giordano · Cerevel Therapeutics
- Gabrielle Sulzberger · Cerevel Therapeutics
- John Renger · Cerevel Therapeutics
- Kathleen Tregoning · Cerevel Therapeutics
- Kenneth DiPietro · Cerevel Therapeutics
- Marijn Dekkers · Cerevel Therapeutics
- Mark Bodenrader · Cerevel Therapeutics
- Norbert G. Riedel · Cerevel Therapeutics
- Paul Burgess · Cerevel Therapeutics
- Raymond Sanchez · Cerevel Therapeutics
- Ron Renaud · Cerevel Therapeutics
- Ruth McKernan · Cerevel Therapeutics
- Scott Akamine · Cerevel Therapeutics
- Suneet Varma · Cerevel Therapeutics
- Susan Altschuller · Cerevel Therapeutics
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.